KRISTEN RATTIGAN: Open Payments
NPI 1154892347 · SENECA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,014 in 55 payments from 17 companies in 2025. Trend: 2023 $1,323 · 2024 $1,223 · 2025 $1,014
Food & beverage: $1,014
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $235 |
| Novo Nordisk Inc | 11 | $208 |
| Grifols USA, LLC | 5 | $99 |
| Abbott Laboratories | 3 | $63 |
| SHIELD THERAPEUTICS INC | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Lundbeck LLC | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
Products named: QULIPTA, Prolastin-C Liquid, Ozempic, REXULTI, FREESTYLE LIBRE 3, ACCRUFER, Rybelsus, XIFAXAN.
Industry payments across PA — which companies pay providers there.
